“…In contrast, requiring or encouraging staff at methadone programs to advise patients of buprenorphine availability was not associated with the number of waivered physicians. Our findings that policies with more detailed guidance to providers were associated with more waivered physicians, in contrast to policies with less specific guidance to providers, are consistent with quality of care studies, which have found that detailed provider guidance, such as that occurring in academic detailing (Jin et al, 2012; Soumerai, 1998), can result in providers changing behavior. It may also be that efforts to enhance the use of buprenorphine through methadone programs, whose patients are clinically different than individuals receiving buprenorphine,(Baxter, Clark, Samnaliev, Leung, & Hashemi, 2011) and which already have an established infrastructure and alternative business model to provide an alternative opioid agonist treatment, are less effective than initiatives targeting broader groups of providers.…”